Why Credo Technology Sank This Week

Credo’s fiscal Q1 results beat: revenue rose 114.7% to $479.0M and adjusted EPS jumped 130% to $1.20, with Q/Q revenue guidance above expectations. However, the stock fell 29.5% after investors focused on deteriorating margins (GAAP gross margin down to 64.5% from 68% last quarter) and a higher-than-expected stock-based compensation charge. Despite growth, valuation remains rich (about 18x next-year revenue), and management guided to an even lower GAAP gross margin, driving a risk-off reaction.

Analysis

This looks less like a demand miss and more like the market punishing a premium multiple that was priced for flawless operating leverage. In AI infrastructure, revenue growth alone no longer protects a stock if GAAP margins compress and equity compensation rises, because investors immediately translate that into slower per-share compounding and a higher effective earnings multiple. That makes the near-term setup fragile: another quarter of margin slippage could drive a second leg lower even if bookings remain strong.

The main beneficiary is not a direct competitor so much as the rest of the AI networking basket with cleaner margin credibility and less dilution risk. Names like AVGO, ANET, and MRVL should be relatively better defended if customers keep spending but become more selective on vendor economics, since procurement can shift toward platforms with broader product breadth and more stable gross margins. The second-order effect is that CRDO can still win sockets while losing investor support, which often leads to multiple compression before fundamentals actually roll over.

The key catalyst window is 1-2 quarters: watch GAAP gross margin, SBC as a percentage of revenue, and whether management can re-accelerate guide without leaning on stock-based pay. The contrarian risk is that the selloff is overdone if the margin dip is mix-driven and temporary, because triple-digit growth can absorb some dilution if operating leverage resumes. The thesis breaks if margins stabilize back above the recent range and guidance steps up again; otherwise, this is a classic quality-of-earnings de-rating that can persist for months.

Key Decisions for Investors

• Underweight/avoid CRDO for now; wait for a cleaner entry only if GAAP gross margin stabilizes and SBC trends down for 1-2 quarters.
• Pair trade: long AVGO or ANET versus short CRDO on any rebound, targeting relative underperformance if the market continues to reward margin quality over pure growth.
• Use a tactical CRDO short only into relief rallies, with the stop set at a confirmed margin re-acceleration or a raise in forward gross margin guidance.
• Watch the next earnings print as the falsifier: if CRDO can hold or improve GAAP gross margin despite continued revenue growth, the de-rating is likely complete.